Patent 7662577 was granted and assigned to Athera Biotechnologies AB on February, 2010 by the United States Patent and Trademark Office.
A method of and kit for diagnosing cardiovascular disease in a human involves assessing the presence and/or concentration of antibodies to platelet activating factor (PAF) in a sample of body fluid of the human.